Latest Breaking News On - Amputation pain - Page 1 : comparemela.com

Share this article Share this article CLEVELAND and ALISO VIEJO, Calif., Jan. 7, 2021 /PRNewswire/  Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain,  announced today the achievement of two milestones in its pivotal QUEST (High-Fre QUEncy Nerve Block for Po ST-Amputation Pain) study.  QUEST is a 180-subject, randomized, double blinded, active sham controlled clinical trial that is being conducted under an Investigational Device Exemption (IDE).  QUEST is designed to assess the safety & effectiveness of the Company s Altius ® High-Frequency Nerve Block system to treat intractable post-amputation pain. Post-amputation pain is a significant unmet medical need, as existing treatment options are limited, and consist primarily of opioids and gabapentinoids. 

United statesKevin kilgoreDavid veinoNiloy bhadraAmy smithNeuros medical incNational principal investigatorData monitoring committeeAmputee coalitionCompany altiusCarolinas pain instituteCase western reserve universityNeuros medicalNerve blockAmputation painInvestigational device exemption